Teva: Scaling Innovative Medicine with Align
"We are already seeing the benefits of Align. We reduced admin efforts from days to months, enabling our field team to focus on more strategic activities."
Aditya Kumar, senior manager of digital commercial technology at Teva, shares how Align helped managing multiple product launches across Europe and the transition from manual to automated processes. To support a major organizational shift toward centralization and standardization, the company partnered with Veeva to establish a consistent operational foundation across its European markets.
Scaling operations across diverse markets
Managing frequent launches was previously a manual, labor-intensive process. As Teva reorganized to achieve greater harmonization, it needed to eliminate administrative bottlenecks that slowed down field teams. The primary challenge was replacing these manual efforts with a centralized system that could support both innovative and generic medicine portfolios across Europe.
Automated alignment and precise targeting
The company implemented Align to automate entire territory management and field planning processes. Following successful implementations in Switzerland and the U.K., the solution is now expanding throughout Europe. This automated approach enables highly specific targeting for innovative medicines while ensuring field reps have the right data to perform their activities efficiently.
Reducing administrative efforts by months
The transition to an automated system has reduced administrative efforts by months, allowing reps to focus more on their engagement with healthcare professionals. By using a centralized rule engine, the company has gained clear visibility into performance goals and objectives. This transformation has created a scalable foundation for growth, enabling the team to work more effectively across the European landscape.
Learn more about how Veeva Vault CRM Align helps life sciences achieve the right alignments, faster.
